SCHEMBL7012658

SCHEMBL7012658

Cn1c(=O)c2cc(CCl)sc2n(CC2CC2)c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
LMNA P02545 2/20 0.43
POLB P06746 2/20 0.43
PARG Q86W56 7/20 0.40
PDE5A O76074 3/20 0.37
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
CYP3A4 P08684 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ADORA1 P30542 1/20 0.33
MAPT P10636 2/20 0.32
KDM4E B2RXH2 1/20 0.32
PKM P14618 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7014557 0.79 PDE1A (0.42) ALDH1A1LMNAPARGPDE5APDE3B
SCHEMBL7008632 0.76 BRD4 (0.41) ALDH1A1LMNAPOLBPARGCYP3A4
SCHEMBL7014116 0.75 PDE2A (0.42) ALDH1A1LMNAPARGMEN1KMT2A
SCHEMBL7008006 0.73 PARG (0.43) ALDH1A1LMNAPOLBPARGPDE5A
SCHEMBL4803221 0.64 ALDH1A1 (0.43) ALDH1A1LMNAPOLBPARGPDE5A
SCHEMBL6350931 0.64 NOTUM (0.44) ALDH1A1LMNAPOLBPARGPDE5A
SCHEMBL5403546 0.64 PDE5A (0.45) ALDH1A1LMNAPOLBPARGPDE5A
SCHEMBL7007286 0.64 PDE1B (0.38) ALDH1A1PARGPDE5APDE3BPDE3A
SCHEMBL6254904 0.64 MAPK8 (0.41) ALDH1A1LMNAPARGADORA1
SCHEMBL5864669 0.62 PDE1B (0.47) LMNAPDE3BPDE3ASMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1107973-B1 NOVEL THIENO[2,3-d]PYRIMIDINEDIONES, PROCESS FOR THEIR PREPARATION AND USE THEREOF IN THERAPY ASTRAZENECA AB (SE) 2003-11-05 EP disclosed
US-6300334-B1 DRUGS FOR TREATMENT OF RESPIRATORY SYSTEM DISORDERS ASTRAZENECA AB (SE) 2001-10-09 US disclosed
EP-1107973-A1 NOVEL COMPOUNDS AstraZeneca AB (SE) 2001-06-20 EP disclosed
WO-2000012514-A1 NOVEL COMPOUNDS ASTRAZENECA AB (SE) 2000-03-09 WO disclosed